Proposed DSM-5 sexual interest/arousal disorder versus DSM-IV distinct HSDD and FSAD

2011 ◽  
Author(s):  
Anita H. Clayton
Keyword(s):  
Sexual Interest ◽  
Dsm 5 ◽  
Arousal Disorder ◽  
Dsm Iv

scholarly journals Evaluation of sexual dysfunction in gynecologic cancer survivors using DSM-5 diagnostic criteria

2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Hao Lin ◽  
Hung-Chun Fu ◽  
Chen-Hsuan Wu ◽  
Yi-Jen Tsai ◽  
Yin-Jou Chou ◽  
...  
Keyword(s):  
Logistic Regression ◽  
Endometrial Cancer ◽  
Sexual Dysfunction ◽  
Cancer Survivors ◽  
Diagnostic Criteria ◽  
Sexual Interest ◽  
Gynecologic Cancer ◽  
Multiple Logistic Regression ◽  
Dsm 5 ◽  
Arousal Disorder

Abstract Background In gynecologic cancer survivors, female sexual dysfunction (FSD) remains under-investigated. We attempted to estimate the prevalence of FSD associated with distress in gynecologic cancer survivors using diagnostic and statistical manual of mental disorders fifth edition (DSM-5) diagnostic criteria and to identify women at risk for FSD. Methods We conducted a cross-sectional analysis of premenopausal women aged 20–50 with various gynecologic cancers at least one year after treatment between January 2017 and December 2019. Data of sociodemographics and physical conditions were collected via face-to-face interview during outpatient clinic visits. The domains we used to define FSD were based on DSM-5 diagnostic criteria. Statistical analysis was carried out using Student's t test, Chi-square test and multiple logistic regression. Results A total of 126 gynecologic cancer survivors with a mean age of 42.4 years were included for analysis and 55 of them (43.7%) were diagnosed as having FSD associated with distress based on DSM-5 criteria. More than half of women (65.1%) reported decreased sexual satisfaction after cancer treatment. According to DSM-5 definition, the most common female sexual disorders were sexual interest/arousal disorder (70.9%), followed by genitopelvic pain/penetration disorder (60.0%), and orgasmic disorder (20.0%). In multiple logistic regression model, endometrial cancer diagnosis was the only independent factor predicting less influence of cancer treatment on FSD (OR 0.370; 95% CI 0.160, 0.856). Conclusion The first study to use DSM-5 criteria for estimation of FSD prevalence. This enables clinicians to identify which women are actually needed to seek medical help. A prevalence of 43.7% of FSD associated with distress was found in a group of gynecologic cancer survivors with the most common being sexual interest/arousal disorder. Endometrial cancer survivors were at low risk for developing FSD after treatment.

Difference or dysfunction?: Deconstructing desire in the DSM-5 diagnosis of Female Sexual Interest/Arousal Disorder

2021 ◽  
Vol 31 (1) ◽  
pp. 81-98 ◽  
Author(s):  
Emily J Thomas ◽  
Maria Gurevich
Keyword(s):  
Sexual Desire ◽  
Conceptual Analysis ◽  
Female Sexuality ◽  
Sexual Interest ◽  
Women's Bodies ◽  
Dsm 5 ◽  
Female Sexual Desire ◽  
Arousal Disorder ◽  
Healthy Female ◽  
Sociocultural Contexts

This article answers ongoing calls within critical sexuality scholarship to explore how constructions of women’s bodies influence and are influenced by broader sociocultural contexts. Specifically, this article offers a conceptual analysis of female sexual desire, highlighting the deeply political nature of its pathologization. We briefly explore dominant definitions and models of sexual desire to highlight the erasure of embodied desire as an important part of healthy female sexuality. The DSM-5 diagnosis of Female Sexual Interest/Arousal Disorder is critically analyzed to highlight how desire differences are framed as gendered, individual problems which sidelines relational, contextual, and sociopolitical factors contributing to individual distress. When the language of desire is displaced by the language of interest (particularly when framed as receptivity), the capacity to theorize wanting and entitlement is undermined. We argue that the pathologization of diverse desires obscures possibilities for embodied wanting and neglects the consideration that all types of desire (absent, frequent, physical, emotional) may represent normal sexual variations.

Sexual Dysfunctions

2018 ◽  
Author(s):  
Lancer Naghdechi ◽  
Atef Bakhoum ◽  
Waguih William IsHak
Keyword(s):  
Sexual Interest ◽  
Sexual Pleasure ◽  
Treatment Modalities ◽  
Sexual Dysfunctions ◽  
Dsm 5 ◽  
Delayed Ejaculation ◽  
Arousal Disorder ◽  
Erectile Disorder ◽  
Female Orgasmic Disorder ◽  
Orgasmic Disorder

Sexuality and sexual medicine is an important and often understudied aspect of medicine and psychiatry. Often, patients and physicians avoid conversations having to do with sex. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) defines sexual dysfunctions as “a heterogeneous group of disorders that are typically characterized by a clinically significant disturbance in a person’s ability to respond sexually or to experience sexual pleasure”. This review addresses the diagnostic criteria, epidemiology, etiology, phenomenology, diagnostic work-up, treatment modalities, guidelines, and prognosis for sexual dysfunctions including male hypoactive sexual desire disorder, erectile disorder, premature and delayed ejaculation, female sexual interest/arousal disorder, female orgasmic disorder, and genito-pelvic pain/penetration disorder. The table lists sexual dysfunctions listed in DSM-5 with associated prevalence. This review contains 1 figure, 1 table and 20 references Key Words: DSM-5, erectile disorder, female orgasmic disorder, female sexual interest/arousal disorder, painful intercourse, premature ejaculation, sexual dysfunction

scholarly journals Women's Endorsement of Different Models of Sexual Functioning Supports Polythetic Criteria of Female Sexual Interest/Arousal Disorder in DSM‐5

2015 ◽  
Vol 12 (9) ◽  
pp. 1978-1980 ◽  
Author(s):  
Lori A. Brotto ◽  
Cynthia A. Graham ◽  
Laurel Q. Paterson ◽  
Morag A. Yule ◽  
Kenneth J. Zucker
Keyword(s):  
Sexual Functioning ◽  
Sexual Interest ◽  
Dsm 5 ◽  
Arousal Disorder

Autismus-Spektrum Störung nach DSM-5

2014 ◽  
Vol 42 (3) ◽  
pp. 185-192 ◽  
Author(s):  
Christine M. Freitag
Keyword(s):  
Dsm 5 ◽  
Icd 10 ◽  
Dsm Iv

Die Autismus-Spektrum Störung (ASS) wird in DSM-5 als eine Erkrankung aus den ICD-10 bzw. DSM-IV TR-Diagnosen frühkindlicher Autismus, Asperger Syndrom und atypischer Autismus/PDD-nos zusammengefasst und weist entsprechend revidierte Kriterien auf. In dem vorliegenden Artikel werden diese Kriterien vergleichend dargestellt, Studien zu Validität und Reliabilität der neuen ASS-Diagnose präsentiert und offene Fragen diskutiert. Ein Ausblick auf die klinische und wissenschaftliche Bedeutung wird gegeben.

Veränderungen in der Prävalenz substanzbezogener Störungen durch den Wechsel von DSM-IV zu DSM-5

Suchttherapie ◽  
2015 ◽  
Vol 16 (S 01) ◽  
Author(s):  
D Piontek ◽  
E Gomes de Matos ◽  
L Kraus
Keyword(s):  
Dsm 5 ◽  
Dsm Iv

Suchterkrankungen im Diagnostischen und Statistischen Manual Psychischer Störungen DSM-5

2015 ◽  
Vol 12 (02) ◽  
pp. 110-117
Author(s):  
O. Pogarell ◽  
G. Koller
Keyword(s):  
Addictive Disorders ◽  
Dsm 5 ◽  
Icd 10 ◽  
Dsm Iv

Zusammenfassung Hintergrund: Im Jahr 2014 wurde das DSM-IV durch die fünfte Version des Diagnostischen und Statistischen Manuals Psychischer Störungen (DSM-5) abgelöst. In der vorliegenden Übersicht soll auf die Darstellung der Abhängigkeitserkrankungen im DSM-5 (Kapitel: Substance Related and Addictive Disorders, in der Übersetzung: Störungen im Zusammenhang mit psychotropen Substanzen und abhängige Verhaltensweisen) eingegangen werden. Ziel: Nach einem Überblick über die neue Systematik werden die entsprechenden Änderungen und Besonderheiten gegenüber DSM-IV und ICD-10 erläutert, sowie die Rezeption im deutschsprachigen Raum dargestellt.

Historische Entwicklung, Diagnostik und Klassifikation der Somatoformen Störungen – Vergleich von ICD-10, DSM-IV-TR und DSM-5

2014 ◽  
Vol 11 (03) ◽  
pp. 149-155
Author(s):  
M. Zaudig
Keyword(s):  
Anxiety Disorder ◽  
Somatic Symptom ◽  
Somatic Symptom Disorder ◽  
Historische Entwicklung ◽  
Dsm 5 ◽  
Illness Anxiety Disorder ◽  
Icd 10 ◽  
Dsm Iv ◽  
Illness Anxiety

ZusammenfassungDer vorliegende Artikel beschreibt die aktuellen diagnostischen Entwicklungen im Bereich der Somatoformen Störung unter Zugrundelegung der aktuellen S3-Leitlinien für „Nichtspezifische funktionelle und somatoforme Körperbeschwerden“ und der historischen Entwicklung der Somatoformen Störungen (einschließlich der Hypochondrie). Neben einem Vergleich von ICD-10 mit DSM-IV-TR und DSM-5 werden die neuen Kriterien für Somatic Symptom Disorder und Illness Anxiety Disorder (vormals Hypochondrie) nach DSM-5 vorgestellt und diskutiert.

Sign in / Sign up

Export Citation Format

Share Document